Intrinsic Value

TG Therapeutics, Inc. (TGTX)

$13.845

-0.07 (-0.47%)

Enterprise Value -73,838,328,071,138.77
Net Debt 17.86
Equity Value -73,838,328,071,156.63
Shares Outstanding 148.51
Equity Value Per Share -497,199,456,415.88



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt